Found: 16
Select item for more details and to access through your institution.
Evidence for rCBV as an early response marker following bevacizumab treatment.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 11, p. 1539, doi. 10.1093/neuonc/nov199
- By:
- Publication type:
- Article
Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 11, p. 1525, doi. 10.1093/neuonc/nov117
- By:
- Publication type:
- Article
The CD40/CD40L axis in glioma progression and therapy.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 11, p. 1428, doi. 10.1093/neuonc/nov138
- By:
- Publication type:
- Article
Preclinical activity of combined HDAC and KDM1A inhibition in glioblastoma.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 11, p. 1463, doi. 10.1093/neuonc/nov041
- By:
- Publication type:
- Article
Telomere maintenance and the etiology of adult glioma.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 11, p. 1445, doi. 10.1093/neuonc/nov082
- By:
- Publication type:
- Article
CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 11, p. 1497, doi. 10.1093/neuonc/nov092
- By:
- Publication type:
- Article
Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 11, p. 1504, doi. 10.1093/neuonc/nov104
- By:
- Publication type:
- Article
Society news.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 11, p. 1541, doi. 10.1093/neuonc/nov251
- Publication type:
- Article
The metalloprotease-disintegrin ADAM8 contributes to temozolomide chemoresistance and enhanced invasiveness of human glioblastoma cells.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 11, p. 1474, doi. 10.1093/neuonc/nov042
- By:
- Publication type:
- Article
pH-weighted molecular imaging of gliomas using amine chemical exchange saturation transfer MRI.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 11, p. 1514, doi. 10.1093/neuonc/nov106
- By:
- Publication type:
- Article
From the clinician's point of view - What is the status quo of positron emission tomography in patients with brain tumors?
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 11, p. 1434, doi. 10.1093/neuonc/nov118
- By:
- Publication type:
- Article
CD40/CD40L expression correlates with the survival of patients with glioblastomas and an augmentation in CD40 signaling enhances the efficacy of vaccinations against glioma models.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 11, p. 1453, doi. 10.1093/neuonc/nov090
- By:
- Publication type:
- Article
Dynamic susceptibility contrast MRI measures of relative cerebral blood volume continue to show promise as an early response marker in the setting of bevacizumab treatment.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 11, p. 1538, doi. 10.1093/neuonc/nov163
- By:
- Publication type:
- Article
Highlights from the Literature.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 11, p. 1431, doi. 10.1093/neuonc/nov252
- Publication type:
- Article
Expression profiles of 151 pediatric low-grade gliomas reveal molecular differences associated with location and histological subtype.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 11, p. 1486, doi. 10.1093/neuonc/nov045
- By:
- Publication type:
- Article
Withholding temozolomide in glioblastoma patients with unmethylated MGMT promoter--still a dilemma?
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 11, p. 1425, doi. 10.1093/neuonc/nov198
- By:
- Publication type:
- Article